ASP Isotopes Inc. (ASPI) Spending and interest coverage
- R&D / revenue · 12 months: Value 71.42%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 60.48%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 71.42% | Research and development expense / revenue. Period ending 2026-06-30. $22.04M ÷ $30.85M × 100 ≈ 71.42% |
| Stock-based compensation / revenue · 12 months | 60.48% | Share-based compensation / revenue. Period ending 2026-06-30. $18.66M ÷ $30.85M × 100 ≈ 60.48% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 22.04M USD | Research and Development Expense |
| Revenue | 30.85M USD | |
| Stock-based compensation | 18.66M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -99.07M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $22.04M | $30.85M | $18.66M | $-99.07M | (m) | 71.42% | 60.48% | (m) | (m) |
| 2026-03-31 | $16.09M | $26.93M | $18.55M | $-76.84M | (m) | 59.76% | 68.88% | (m) | (m) |
| 2025-12-31 | $12.36M | $23.85M | $16.02M | $-59.91M | (m) | 51.82% | 67.19% | (m) | (m) |
| 2025-09-30 | $6.92M | $8.38M | $13.06M | $-42.54M | (m) | 82.60% | 155.84% | (m) | (m) |
| 2025-06-30 | $4.86M | $4.58M | $10.65M | $-33.00M | (m) | 106.08% | 232.44% | (m) | (m) |
| 2025-03-31 | $4.45M | $4.41M | $8.74M | $-28.49M | (m) | 101.09% | 198.33% | (m) | (m) |
| 2024-12-31 | $3.14M | $4.14M | $8.56M | $-26.35M | (m) | 75.74% | 206.59% | (m) | (m) |
| 2024-09-30 | $1.79M | $3.38M | $8.45M | $-22.73M | (m) | 52.85% | 249.84% | (m) | (m) |
| 2024-06-30 | $992.80K | $2.30M | $8.46M | $-21.24M | $201.41K | 43.25% | 368.37% | -105.46× | Reported |
| 2024-03-31 | $772.38K | $1.27M | $8.31M | $-18.13M | $132.34K | 60.66% | 652.86% | -137.02× | Reported |
| 2023-12-31 | $764.58K | $433.03K | $8.74M | $-16.04M | $118.55K | 176.57% | 2019.23% | -135.32× | Reported |
| 2023-09-30 | $781.05K | (m) | $7.64M | $-13.48M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $1.29M | (m) | $6.29M | $-11.49M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $1.19M | (m) | $4.12M | $-7.97M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $1.27M | (m) | $2.00M | $-5.10M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orion S.A. (OEC) | $0.341B | -3.89 | |
| Arq, Inc. (ARQ) | United States | $0.088B | -2.08 |
| FLEXIBLE SOLUTIONS INTERNATIONAL INC (FSI) | $0.075B | -27.31 | |
| FLOTEK INDUSTRIES INC/CN/ (FTK) | United States | $1.050B | 22.42 |
| WD 40 CO (WDFC) | United States | $2.647B | 30.12 |
| CABOT CORP (CBT) | United States | $4.062B | 24.66 |
| Element Solutions Inc (ESI) | United States | $8.402B | 55.83 |